NovoCure Ltd — Director's Dealing 2019

Jan 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-01-09

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-09	Ordinary Shares	M	75000	$14.37	Acquired	221558	Direct
2019-01-09	Ordinary Shares	S	75000	$40.00	Disposed	146558	Direct
2019-01-09	Ordinary Shares	M	25000	$11.46	Acquired	171558	Direct
2019-01-09	Ordinary Shares	S	25000	$40.00	Disposed	146558	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-09	Options to Buy Ordinary Shares	$14.37	M	75000	Acquired	2025-02-23	Ordinary Shares (75000)	Direct
2019-01-09	Options to Buy Ordinary Shares	$11.46	M	25000	Acquired	2026-02-24	Ordinary Shares (25000)	Direct

Footnotes

F1: These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

F3: Fully vested as of the date hereof.